1[1]Kocisis J. New strategies for treating chronic depression[J]. J Clin Psychiatry, 2000, 60 ( Suppl 11 ): 42.
2[2]Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment- resistant depression on health care utilization and costs[J]. J Clin Psychiatry, 2002, 63:963.
3[3]Thase ME. What role do atypical antipsychotic drugs have in treatment - resistant depression [ J ]. J Clin Psychiatry, 2002,63:95.
4[4]Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression [ J ]. J Clin Psychiatry, 1999,60: 256.
5[5]Hirose S, Ashby CR. An open pilot study combining resperidone and a selective serotonin reuptake inhibitor as inintal antidepressant therapy[J]. J Clin Psychiatry, 2002, 63:733.
6[6]Dibe S, Andersen SW, Sanger TM, et al. Efficacy of olanzapine and olanzapine- fluoxetine combination in the treatment of bipolar I depression[J]. Arch Gen Psychiatry, 2003, 6 011:1079.
7[7]Bartzokis G, Freeman T, Roca V, et al. Risperidone in the treatment of chronic combat - related post - traumatic stress disorder[J]. Int J Neuropsychopharmacol, 2002, 5(Suppl 1 ):S130.
8[8]McDougle CJ. Risperidone plus SSRI improves symptoms of obsessive- compulsive disorder [ J ]. Arch Gen Psychiatry,2000,57: 794.
